<DOC>
	<DOCNO>NCT01911663</DOCNO>
	<brief_summary>This study randomize , double-blind , placebo-controlled clinical trial design evaluate effect Korean red ginseng supplementation glucose control subject impair fast glucose , impair glucose tolerance newly-diagnosed type 2 Diabetes Mellitus establish clinical evidence glucose control effect KRG .</brief_summary>
	<brief_title>The Effect Korean Red Ginseng Supplementation Glucose Control</brief_title>
	<detailed_description>Study participant , age 20 70 , recruit health checkup center Ilsan hospital ( Gyeonggi-do , Korea ) advertisements local newspaper . After glucose screen test , subject IFG ( 100 mg/dL ≤ fast blood glucose ≤ 125mg/dL ) , IGT ( 140mg/dL ≤ 2-h OGTT ) , newly-diagnosed T2DM ( fast glucose ≥ 126 mg/dL ) enrol study . Exclusion criterion select patient meet : 1 ) Taking glucose-lowering medication insulin injection . 2 ) Chronic alcoholism evidence alcoholism . 3 ) Pregnant breast feeding . 4 ) Having chronic gastrointestinal disorder . 5 ) Showing sign nutrient deficiency malnutrition . 6 ) Patients serious kidney problem . 7 ) Patients serious liver problem . 8 ) Patients whose job could threat hypoglycemia occur . 9 ) Patients experienced complication headache , insomnia , heart palpitation raise blood pressure eat red ginseng . 10 ) Other patient consider unsuitable study researcher This study design 12-week randomize , double-blinded , placebo-controlled trial . Sixty subject randomly assign receive placebo ( corn starch ) 500 mg KRG . Both group consume 10 capsule per day , three time daily breakfast ( 3 capsule ) , lunch ( 3 capsule ) dinner ( 4 capsule ) , come total 5.0g daily . Red ginseng placebo capsule provide Korea Ginseng Cooperation ( KGC , Daejeon , Korea ) . Subjects meet investigational team four different time point : Screening ( Week -1 ) , randomization treatment baseline ( Week 0 ) , treatment midpoint ( Week 6 ) , treatment endpoint ( Week 12 ) . Daily intake 24-hour recall method physical activity measure baseline ( Week 0 ) , midpoint ( Week 6 ) , endpoint ( Week 12 ) treatment period . Compliance study restriction capsule consumption monitor via daily documentation subject individualize study calendar end-study count return capsule .</detailed_description>
	<criteria>subject IFG ( 100 mg/dL ≤ fast blood glucose ≤ 125mg/dL ) , IGT ( 140mg/dL ≤ 2h OGTT ) , newlydiagnosed T2DM ( fast glucose ≥ 126 mg/dL ) enrol study . Exclusion criterion select patient meet : 1 ) Taking glucoselowering medication insulin injection . 2 ) Chronic alcoholism evidence alcoholism . 3 ) Pregnant breast feeding . 4 ) Having chronic gastrointestinal disorder . 5 ) Showing sign nutrient deficiency malnutrition . 6 ) Patients serious kidney problem . 7 ) Patients serious liver problem . 8 ) Patients whose job could threat hypoglycemia occur . 9 ) Patients experienced complication headache , insomnia , heart palpitation raise blood pressure eat red ginseng . 10 ) Other patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>